Candel Therapeutics Inc

CADL's Fundamental analysis

Select the Comparisons :

None ▼

Select the Ratio:

None▼

None ▼

None▼

CADL Growth rates comparisons

Candel Therapeutics Inc 's sales fell in the second quarter of 2025 from the same quarter a year ago.

Biotechnology & Pharmaceuticals industry recorded growth of revenues by 1.92 %

Candel Therapeutics Inc net loss decreased from $-22 millions, to $-5 millions in second quarter of 2025,

• More on CADL's Growth

CADL's Valuation comparisons

Candel Therapeutics Inc
realized a net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 3.4 in trailing twelve-month period.

Company

PE TTM

Industry

PE TTM

Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 7.04.

• More on CADL's Valuation

Total Debt (Millions $)	8
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Revenue/Employee (TTM) $	-
Net Income/Employee (TTM) $	-
Receivable Turnover (TTM)	-
Tangible Book Value (Per Share $)	1.75

CADL's Valuation comparisons

Candel Therapeutics Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 3.4 in trailing twelve-month period.

Company

PE TTM

Industry

PE TTM

Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 7.04.

Candel Therapeutics Inc Price to Book Ratio is at 2.98 lower than Industry Avg. of 2100.73. and higher than S&P 500 Avg. of 0.02

• More on CADL's Valuation

• Market Capitalization (Millions $)	269
• Shares Outstanding (Millions)	51
• Employees	38
• Revenues (TTM) (Millions $)	-
• Net Income (TTM) (Millions $)	-22
• Cash Flow (TTM) (Millions $)	79
• Capital Exp. (TTM) (Millions $)	0
• Total Debt (Millions $)	8
• Dividend TTM ($)	0 $
• Dividend Yield TTM (%)	-
• Revenue/Employee (TTM) $	-
• Net Income/Employee(TTM) $	-
• Receivable Turnover Ratio (TTM)	-
• Tangible Book Value (Per Share $)	1.75

• Market Capitalization (Millions $)	269
• Shares Outstanding (Millions)	51
• Employees	38
• Revenues (TTM) (Millions $)	-
• Net Income (TTM) (Millions $)	-22
• Cash Flow (TTM) (Millions $)	79
• Capital Exp. (TTM) (Millions $)	0

	*Ratio*
• Capital Ratio (MRQ)	7.04
• Total Debt to Equity (MRQ)	0.08
• Tangible Leverage Ratio (MRQ)	0.17
• Asset Turnover Ratio (TTM)	-
• Inventory Turnover Ratio (TTM)	-

CADL's Profitability Comparisons

• More on CADL's Key Ratios

Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.